Combined Inclusion Criteria for Health Care Service Delivery Innovations and Health Care Policy Innovations
The innovation relates to patient care delivery processes or involves health care policy.
In general, innovations that involve devices, tools, technology, software, curricula, procedures, or changes to the physical environment qualify only if they have a direct or indirect impact on the delivery of health care services to patients.
Health Care Service Delivery Innovation
Health Care Policy Innovation
The innovation changes usual patient care processes and/or associated health services delivery. It does not have to involve direct patient care or direct contact with health care consumers. However, it must have important implications for the delivery of patient care—whether preventive, emergent, chronic, acute, rehabilitative, long-term, or end-of-life.
A policy is a rule, regulation, directive, incentive, deterrent, or other approach for motivating changes in the behavior of individuals, social groups, or organizational entities. A policy does not need to have the authority of a legal mandate, but it must include some means of motivating behavior change at an individual or organizational level. To be included, a policy must be intended to influence the structures, processes, or outcomes of health care delivery. Policies that involve changes to the social or institutional structures involved in health care (e.g., delivery systems, workforce, financing, or the physical environment), qualify if they are intended to influence the delivery of health care services.
The innovation aims to improve one or more domains of health care quality.
The innovation addresses one or more specific measurable indicators of quality or disparities reduction in the domains defined by the Institute of Medicine: effectiveness, efficiency, equity, patient-centeredness, safety, and timeliness. Policy innovations may also address one or more of the National Quality Strategy aims (better care, healthy people/healthy communities, and affordable care). The indicators do not have to come from an established measure set, but they must be clearly defined and relevant to the quality issue your innovation addresses. Also, the innovation must not contradict established standards of evidence-based care.
The activity or policy is truly innovative in the context of its setting or target population.
For the purposes of the Innovations Exchange, innovation refers to the creative implementation of new or altered products, services, processes, systems, organizational structures, business models, or policies to improve one or more domains of health care quality or reduce health care disparities. In general, it must be clear how an innovation differs from what is regarded as standard practice
or policy in a particular organization and among similar organizations. In making a final decision about innovativeness, the Editorial Team will assess the novelty of the activity or policy in context relative to usual care or typical policies in similar organizations based on information offered when an innovation is submitted, along with its working knowledge of the industry and knowledge by experts. In addition to brand-new ideas, the team will consider activities adapted from other industries to health care, transferred from one health care setting or market segment to another, drawn from settings in other countries, or applied to a new or different patient population. The team will also consider multifaceted innovations, in which the fact that certain activities or policies are combined is the innovation.
Information about the innovation is publicly available.
Enough information must be freely available so that a user of the Innovations Exchange can understand the elements of the innovation and make a decision about adopting it. This requirement does not exclude innovations that incorporate commercial products or other materials for which there may be a fee or licensing requirements. All information about the innovation does not have to be publicly available, but the Editorial Team will need access to information with sufficient detail to produce a comprehensive description.
The innovator (or a representative) will contribute information to the Innovations Exchange.
A person knowledgeable about the innovation must participate in interviews with the Editorial Team and share available written information about the innovation. This person must also confirm that he or she can speak on behalf of any collaborating organizations and provide the name of a contact person who will be listed in the innovation description.
There is reason to believe that the innovation will be effective.
Health Care Service Delivery Innovation
Health Care Policy Innovation
There must be some evidence that the innovation is likely to achieve its goals. Ideally, this would include some quantitative or qualitative support for a link between the activity and improved performance on the defined quality indicator(s). However, if data are unavailable, limited, or lacking in methodological rigor, anecdotal reports of the impact of the innovation may suffice. Otherwise, it may be considered an Innovation Attempt.
There must be some evidence that the innovation is likely to achieve its goals, in terms of health outcomes, behaviors, or
structures. Progress should be measured using clearly defined, relevant
indicators. Indicators may reflect changes in delivery of care (health care
services) as well as changes in ultimate outcomes (health); or changes in social
structures or institutions such as delivery systems, workforce, financing, or
the physical environment. If data are unavailable, limited, or lacking in methodological rigor, anecdotal reports of the impact of the innovation may suffice. Otherwise, it may be considered an Innovation Attempt.
Innovations that fall into any one of these categories will be excluded from the Innovations Exchange.
Product or Technical Innovations. These innovations include new drugs or devices, software design and development, or durable medical equipment or supplies. Although advances in these areas may be innovative, to be eligible for inclusion in the Innovations Exchange, there must be a demonstrated connection to an innovative service delivery change.
Educational Innovations. Innovations such as curriculum redesigns, continuing education certification, or the use of simulators or other technologies for training are outside the scope of the Innovations Exchange.
Clinical Innovations. Pure clinical innovations such as new surgical, medical, or dental therapies or professional techniques are outside the scope of the Innovations Exchange.
Innovations Without Any Evidence of Effect. Innovations without quantitative or qualitative support for a link between the innovation and targeted health care outcomes or processes are outside the scope of the Innovations Exchange.